TY  - GEN
AU  - Hershman,Dawn L
AU  - Unger,Joseph M
AU  - Crew,Katherine D
AU  - Minasian,Lori M
AU  - Awad,Danielle
AU  - Moinpour,Carol M
AU  - Hansen,Lisa
AU  - Lew,Danika L
AU  - Greenlee,Heather
AU  - Fehrenbacher,Louis
AU  - Wade,James L
AU  - Wong,Siu-Fun
AU  - Hortobagyi,Gabriel N
AU  - Meyskens,Frank L
AU  - Albain,Kathy S
TI  - Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy
SN  - 1527-7755
PY  - 2013///0911
KW  - Acetylcarnitine
KW  - administration & dosage
KW  - Adult
KW  - Aged
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Dietary Supplements
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Linear Models
KW  - Mastectomy
KW  - methods
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Nerve Regeneration
KW  - drug effects
KW  - Peripheral Nervous System Diseases
KW  - chemically induced
KW  - Reference Values
KW  - Risk Assessment
KW  - Sensitivity and Specificity
KW  - Severity of Illness Index
KW  - Taxoids
KW  - adverse effects
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2012.44.8738
ER  -